
5-year Outcomes Following a HIFU Focal Therapy Study Demonstrate Impressive Disease Control & Low Side Effect Profiles
July 11, 2018
SonaCare Medical, the leading developer and manufacturer of high intensity focused ultrasound (HIFU) technologies, is pleased to report 5-year outcomes from a multicenter study following focal therapy treatment with its Sonablate technology of 625 medium to high-risk clinically significant non-metastatic prostate cancer patient